You have 9 free searches left this month | to do more

bomedemstat

Bomedemstat is a drug used to treat Extensive Stage Lung Small Cell Carcinoma, Primary Myelofibrosis, and Thrombocythemia, Essential. Bomedemstat is being actively studied in 2 studies; no studies for this drug have been completed so far.

Top SponsorsTop SitesTop Investigators
Imago BioSciences,Inc.Fred Hutch/University of Washington Cancer Consortium
University of WashingtonQueen Mary Hospital
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
I
Extension Study of Bomedemstat (IMG-7289) in Patients With Myeloproliferative Neoplasms
Recruiting
  • Thrombocythemia, Essential
  • Primary Myelofibrosis
  • Bomedemstat
  • Hong Kong, Hong Kong
    Queen Mary Hospital
2022-01-24
Jan 24, 2022
U
Bomedemstat and Maintenance Immunotherapy for Treatment of Newly Diagnosed Extensive Stage Small Cell Lung Cancer
Recruiting
  • Extensive Stage Lung Small Cell Carcinoma
  • Limited Stage Lung Small Cell Carcinoma
  • Bomedemstat
  • Atezolizumab
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-03-30
Mar 30, 2022